Clinical trial
Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy
NCT00409019 · Novartis Pharmaceuticals, Industry · Withdrawn
Key facts
| NCT number | NCT00409019 |
|---|---|
| Title | Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy |
| Official title | A Prospective, Randomized, Trial to Investigate the Effect of Continued Adefovir Versus Combination Regimens of Telbivudine Plus Adefovir, and Telbivudine Plus Tenofovir in Patients With Chronic Hepatitis B and Suboptimal Viral Suppression (PROACTIV Study) |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Hepatitis B |
| Intervention type | Drug |
| Interventions | Telbivudine, Adefovir, Tenofovir |
| Enrollment | 0 |
| Primary completion | Mar 1, 2011 |
| First posted | Dec 8, 2006 |
| Last update posted | Mar 9, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: